This article is more than 5 years old. Information may no longer be current.
Kelman Lecturer: Bimanual MICS advances cataract surgery
Click Here to Manage Email Alerts
CHICAGO — The impact of bimanual microincision cataract surgery can be equated with that of phacoemulsification, according to the first presenter of a new named lecture at the American Academy of Ophthalmology meeting
Bimanual microincision cataract surgery (MICS) is a development that “alters cataract surgery as physicians currently know it,” said I. Howard Fine, MD. Dr. Fine delivered the inaugural Charles D. Kelman Lecture at the AAO meeting here.
Introducing Dr. Fine, David Chang, MD, called him “perhaps the best-known cataract surgeon in the world.” Dr. Fine said he was “humbled” to be named the first Kelman Lecturer. He said Dr. Kelman’s invention of phacoemulsification “was ahead of its time.”
Dr. Fine said he could “only get up to speak in front of you because my wife is here in the audience.”
While 2-mm coaxial phaco “is an improvement worthy of note,” Dr. Fine said, bimanual MICS is better. He said the separate infusion and aspiration function in bimanual MICS is “important in challenging cataract cases.”
Bimanual MICS lets the surgeon have complete control, he said.
“The enormous advantage of bimanual MICS is evident,” he said.
Using bimanual MICS “takes your wrist out of the equation,” Dr. Fine said. “You’re limited to just finger use. It’s like holding a pen, where you set your wrist and let your fingers do all the work.”
The Charles D. Kelman Lecture, which has been endowed with $1 million by the AAO, will honor outstanding innovators in the cataract field. The lecture will be presented annually at the AAO meeting.